Tiger Cub Trust recently filed a report detailing significant stock transactions involving Jacob D. Cohen, who serves as the trustee for the trust. This filing is particularly noteworthy as it reflects a transfer of shares without altering the beneficial ownership of the securities.
Jacob D. Cohen is also the Chief Executive Officer of Mangoceuticals, Inc., which operates within the health services sector. The transactions reported are part of ongoing activities that could influence corporate governance and ownership structures within the industry.
Background
Tiger Cub Trust is an entity based in Texas, as indicated in its filings. The trust has been involved in various transactions related to its holdings in Mangoceuticals, Inc., a company categorized under the SIC code for services-misc health & allied services, NEC. Recent filings from Tiger Cub Trust include multiple Form 4 submissions, with the latest dated October 6, 2026.
What the Filing Says
The recent filing reveals that Jacob D. Cohen transferred 500,000 shares of common stock from his personal holdings to The Tiger Cub Trust. This transaction did not change the beneficial ownership of the shares, as Cohen retains control over the trust. The filing states, "Represents the transfer of shares from Mr. Jacob D. Cohen to that of a trust which Mr. Cohen controls, which did not result in a change of beneficial ownership of such securities." Additionally, Cohen's direct ownership of Mangoceuticals is noted.
Impact
This update may primarily affect shareholders and stakeholders of Mangoceuticals, Inc., as it highlights the internal ownership dynamics of the company. The transfer of shares into a trust may reflect strategic financial planning by Cohen, which could influence investor perceptions and corporate governance practices.
What's Next
The filing does not say what happens next.